During the past decade, Hospital Universitario Pedro Ernesto conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario Pedro Ernesto" #1 sponsor was "Hospital Universitario Pedro Ernesto" with 5 trials, followed by "Hospital Israelita Albert Einstein" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Eurofarma Laboratorios S.A." with 1 trials sponsored and "Gilead Sciences" with 1 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Pedro Ernesto" #1 collaborator was "Ministry of Health, Brazil" with 2 trials as a collaborator, "Rio de Janeiro State Research Supporting Foundation (FAPERJ)" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Centro Universitário Augusto Motta" with 1 trials as a collaborator and "Conselho Nacional de Desenvolvimento Científico e Tecnológico" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario Pedro Ernesto" are "Hypertension" (4 trials), "COVID-19" (2 trials), "Cardiovascular Diseases" (2 trials), "Diabetes Mellitus" (2 trials) and "Antibiotics" (1 trials). Many other conditions were trialed in "Hospital Universitario Pedro Ernesto" in a lesser frequency.

Most popular intervention types in "Hospital Universitario Pedro Ernesto" are "Drug" (15 trials), "Other" (3 trials), "Procedure" (2 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Abiraterone Acetate" (1 trials), "Aliskiren" (1 trials), "Amlodipine" (1 trials) and "BALANCE" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario Pedro Ernesto" are 22 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Universitario Pedro Ernesto". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Hospital Universitario Pedro Ernesto, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario Pedro Ernesto, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 7 trials that are defined as “Not Applicable".